Terms: = Endocrine gland cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468
84 results:
1. The clinical efficacy of Apatinib plus Ba Zhen granules in the treatment of advanced unresectable differentiated thyroid cancer and their influence on immune factors.
Bai Y; Jin J; Liu Y; Zhang B; Li J
Pak J Pharm Sci; 2023 May; 36(3(Special)):935-939. PubMed ID: 37587701
[TBL] [Abstract] [Full Text] [Related]
2. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.
Kang OJ; Lee SW; Kim JH; Park JY; Suh DS; Kim DY; Kim JH; Kim YM; Kim YT
Int J Gynecol Cancer; 2023 Nov; 33(11):1743-1749. PubMed ID: 37541685
[TBL] [Abstract] [Full Text] [Related]
3. Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study.
Kato N; Yamaguchi A; Sugata S; Hamada T; Furuya N; Mizumoto T; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Tazuma S; Sudo T; Kido M; Ito T; Kuraoka K; Kohno H
BMC Gastroenterol; 2023 May; 23(1):138. PubMed ID: 37127562
[TBL] [Abstract] [Full Text] [Related]
4. The Predicting Role of Serum TSGF and sil-2R for the Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Xu X; Wang W; Sun T; Tian B; Du L; Jing J
Dis Markers; 2022; 2022():3730679. PubMed ID: 36092957
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence of precursor lesions (P53 signature, SCOUT, stil, STIC) in fallopian tubes resected for non-neoplastic causes.
Tewari S; Misra V; Kumar V; Mishra RR; Yadav K; Paridhi ; Sangma H
Indian J Pathol Microbiol; 2022; 65(3):610-616. PubMed ID: 35900489
[TBL] [Abstract] [Full Text] [Related]
7. Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling.
Huo Y; Yang J; Zheng J; Xu D; Yang M; Tao L; Yao H; Fu X; Yang J; Liu D; Hua R; Zhang J; Sun Y; Hu L; Liu W
Cell Prolif; 2022 May; 55(5):e13237. PubMed ID: 35487760
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid cancer.
Li N; Zhang J; Meng X; Yao W
J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
[TBL] [Abstract] [Full Text] [Related]
9. Effects of Regional and General Anesthesia on the Therapeutic Outcome of Benign Thyroid Nodules Treated with High Intensity Focused Ultrasound (HIFU).
Vorländer C; Fischer A; Korkusuz H
World J Surg; 2022 May; 46(5):1076-1081. PubMed ID: 35072745
[TBL] [Abstract] [Full Text] [Related]
10. Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the Prostate, Lung, Colorectal and Ovarian cancer Screening Trial.
King LA; Wentzensen N; Purdue MP; Katki HA; Pinto LA; Trabert B
Ann Epidemiol; 2022 Apr; 68():1-8. PubMed ID: 34906633
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer.
Li H; Wu M; Wu Z; Liang J; Wang L; Yang X; Lin Z; Li J
Cancer Immunol Immunother; 2022 Jun; 71(6):1519-1530. PubMed ID: 34724091
[TBL] [Abstract] [Full Text] [Related]
12. Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of stil in Pancreatic cancer.
Ye Z; Zhu Z; Xie J; Feng Z; Li Y; Xu X; Li W; Chen W
Int J Nanomedicine; 2020; 15():9859-9873. PubMed ID: 33324055
[TBL] [Abstract] [Full Text] [Related]
13. Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?
Grandi G; Perrone AM; Perrone A; Mandato VD; Comerci G; Sammarini M; Merisio C; Amadori A; Stefanetti M; Martinello R; Facchinetti F; De Iaco P;
Maturitas; 2021 Jan; 143():59-64. PubMed ID: 33308637
[TBL] [Abstract] [Full Text] [Related]
14. Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis.
Erturk A; Kuru O; Akgor U; Boyraz G; Cakir C; Turan T; Ozgul N; Salman C; Yuce K
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):862-864. PubMed ID: 33218402
[TBL] [Abstract] [Full Text] [Related]
15. Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian cancer.
Lakis S; Kotoula V; Koliou GA; Efstratiou I; Chrisafi S; Papanikolaou A; Zebekakis P; Fountzilas G
Cancer Genomics Proteomics; 2020; 17(5):529-541. PubMed ID: 32859631
[TBL] [Abstract] [Full Text] [Related]
16. The Association and Significance of p53 in Gynecologic cancers: The Potential of Targeted Therapy.
Nakamura M; Obata T; Daikoku T; Fujiwara H
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31689961
[TBL] [Abstract] [Full Text] [Related]
17. [Spontaneous Tumor Lysis Syndrome in a Patient with Testicular Malignant Lymphoma : A Case Report].
Ichikawa K; Momose H; Mizobuchi SI; Itami Y; Nakahama T; Matsumoto Y; Nakamura T
Hinyokika Kiyo; 2019 Feb; 65(2):49-53. PubMed ID: 31067843
[TBL] [Abstract] [Full Text] [Related]
18. [Metachronous Development of Mantle Cell Lymphoma during Active Surveillance in a Patient with Stage I Testicular cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
19. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
[TBL] [Abstract] [Full Text] [Related]
20. Fallopian Tube Lesions in Women at High Risk for Ovarian cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract] [Full Text] [Related]
[Next]
